The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
pegaspargase
A complex of polyethylene glycol conjugated with L-asparaginase. Asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia, thereby depleting these cells of asparagine and blocking protein synthesis and tumor cell proliferation, especially in the G1 phase of the cell cycle. The agent also induces apoptosis in tumor cells. Pegylation decreases the enzyme's antigenicity. Asparagine is critical to protein synthesis in leukemic cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | L-asparaginase with polyethylene glycol PEG-asparaginase PEG-L-asparaginase PEG-L-asparaginase(K-H) polyethylene glycol-L-asparaginase | |
| |||
| US brand name: | | Oncaspar | |
| |||
| Abbreviations: | | PEG-ASP PEGLA | |
| |||
| Chemical structure: | | (monomethoxypolyethylene glycol succinimidyl)74-L-asparaginase | |
| |||
